Page last updated: 2024-11-05

troglitazone and Edema-Proteinuria-Hypertension Gestosis

troglitazone has been researched along with Edema-Proteinuria-Hypertension Gestosis in 1 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ruebner, M1
Langbein, M1
Strissel, PL1
Henke, C1
Schmidt, D1
Goecke, TW1
Faschingbauer, F1
Schild, RL1
Beckmann, MW1
Strick, R1

Other Studies

1 other study available for troglitazone and Edema-Proteinuria-Hypertension Gestosis

ArticleYear
Regulation of the human endogenous retroviral Syncytin-1 and cell-cell fusion by the nuclear hormone receptors PPARγ/RXRα in placentogenesis.
    Journal of cellular biochemistry, 2012, Volume: 113, Issue:7

    Topics: Alitretinoin; Cell Fusion; Cell Line; Chromans; Cyclic AMP-Dependent Protein Kinases; Endogenous Ret

2012